Press release from Companies

Publicerat: 2025-12-08 10:01:00

PolarCool AB: PolarCool Signs Multi-Unit Agreement with Premier League Club Sunderland AFC

The Med-Tech company PolarCool AB (publ.) announces that it has entered into a three-year multi-unit agreement with English Premier League club Sunderland AFC. The club will integrate PolarCap® systems into all three of their elite team’s matchday and training environments to strengthen the club’s concussion management.

Sunderland AFC is a new customer and has chosen to utilize PolarCap® in all of its elite teams in their medical routines for treating players following concussions. A multi-unit agreement provides greater flexibility to ensure access to the treatment for all teams at the same time.

Elite football remains a strategically important and rapidly expanding market for PolarCool. Head injuries and concussions continue to present significant challenges for players, clubs, and governing bodies – resulting in lost playing time, long term health risks, and substantial financial impact. As awareness of PolarCap® grows and the ability to mitigate the effects of head injuries becomes more recognized, PolarCool is experiencing rising interest from leading European clubs across multiple leagues.

Erik Andersson, CEO of PolarCool, comments:

-It is very gratifying that a top club in the Premier League such as Sunderland AFC has chosen PolarCap®. PolarCool strives to make sports safer, and therefore I am especially proud and pleased that the club takes the concussion issue seriously and is introducing the treatment widely across all elite teams. The agreement further strengthens PolarCap® as a reliable solution at the highest level in football.

For more information

Erik Andersson – CEO PolarCool AB (publ.)              
+46 – 73 860 57 00                                                                             
E-mail:
erik.andersson@polarcool.se

About PolarCool AB (publ.)

PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market.

Läs mer hos Cision
Läs mer om PolarCool AB